India to South Africa: Emtricitabine Export Trade Route

The India to South Africa Emtricitabine corridor is one of India's established pharmaceutical export routes, with 78 shipments documented worth a combined $31.3M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's emtricitabine manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $400.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 25.8%, placing it at rank #16 among India's top emtricitabine export destinations globally.

On the import side, key buyers of Indian emtricitabine in South Africa include VIATRIS HEALTHCARE (PTY) LTD,, MACLEODS PHARMACEUTICALS SA, MACLEODS PHARMACEUTICALS SA (PTY) and 20 others. VIATRIS HEALTHCARE (PTY) LTD, is the single largest importer with 10 shipments valued at $14.0M USD.

India's emtricitabine exports to South Africa are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 35 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LTD — together account for 93% of total trade value on this route. The average shipment value of $400.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as triolar tablets (efavirenz 600mg emtricitabine 200mg tenofovir 300mg tablets) bno:beb92310a md.10/23 ed.09/25 ps: 1x30s and triolar tablets (efavirenz 600mg emtricitabine 200mg tenofovir 300mg tablets) bno:beb92309a md.09/23 ed.08/25 ps: 1x30s, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, VIATRIS HEALTHCARE (PTY) LTD, is the largest importer with 10 shipments worth $14.0M USD — representing 45% of all emtricitabine imports from India on this route. A total of 23 buyers are active on this corridor.